- Latest week
- 17 Jul 2026
- Close
- 4.300000
- Fair value
- 13.325026
- Next-week expectancy
- Negative 40.88%
TLRY Chart Pack
Tilray Inc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, TLRY fell 30.19%, moving from 6.16 to 4.30. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -56.04 and has softened across the 12-week window. Market Dynamics is -1.08 on the latest week. Next-week expectancy is negative at 40.88% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 4.30
- 12-Week Change
- -30.19%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 40.88%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -56.04
- Market Dynamics
- -1.08
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 4.30
- 12-Week Change
- -30.19%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 40.88%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -56.04
- Market Dynamics
- -1.08
Over the latest 12 completed weeks ending 2026-07-17, TLRY fell 30.19%, moving from 6.16 to 4.30. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -56.04 and has softened across the 12-week window. Market Dynamics is -1.08 on the latest week. Next-week expectancy is negative at 40.88% based on similar historical setup states.
Industry Peers
United States equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics Inc Class A | NASDAQ | 17 Jul 2026 | 1.01 | 1.30 | 1.00 | 1.21 | 19.80% |
| GELS Gelteq Limited Ordinary Shares | NASDAQ | 17 Jul 2026 | 0.51 | 0.62 | 0.43 | 0.61 | 17.90% |
| ETON Eton Pharmaceuticals Inc | NASDAQ | 17 Jul 2026 | 36.16 | 42.65 | 35.00 | 42.32 | 17.04% |
| CPIX Cumberland Pharmaceuticals Inc | NASDAQ | 17 Jul 2026 | 5.95 | 8.09 | 5.84 | 6.84 | 14.96% |
| HROW Harrow Health Inc | NASDAQ | 17 Jul 2026 | 41.96 | 47.50 | 40.85 | 46.65 | 11.18% |
| OPTH Optimi Health Corp. Common Shares | NASDAQ | 17 Jul 2026 | 4.51 | 5.20 | 4.10 | 5.01 | 11.09% |
| BTAI BioXcel Therapeutics Inc | NASDAQ | 17 Jul 2026 | 0.81 | 1.17 | 0.80 | 0.89 | 9.56% |
| ORGO Organogenesis Holdings Inc | NASDAQ | 17 Jul 2026 | 2.40 | 2.69 | 2.24 | 2.62 | 9.17% |
| PAHC Phibro Animal Health Corporation | NASDAQ | 17 Jul 2026 | 30.89 | 34.96 | 30.64 | 33.31 | 7.83% |
| RMTI Rockwell Medical Inc | NASDAQ | 17 Jul 2026 | 5.71 | 6.19 | 5.51 | 6.13 | 7.18% |
| VTRS Viatris Inc | NASDAQ | 17 Jul 2026 | 16.29 | 17.67 | 16.12 | 17.29 | 6.17% |
| AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock | NASDAQ | 17 Jul 2026 | 16.85 | 18.39 | 16.58 | 17.85 | 5.93% |
| XERS Xeris Pharmaceuticals Inc | NASDAQ | 17 Jul 2026 | 8.35 | 9.00 | 8.00 | 8.80 | 5.45% |
| ELAN Elanco Animal Health | NYSE | 17 Jul 2026 | 24.62 | 26.37 | 24.51 | 25.83 | 4.91% |
| LQDA Liquidia Technologies Inc | NASDAQ | 17 Jul 2026 | 76.53 | 80.42 | 69.71 | 79.94 | 4.46% |
| PRGO Perrigo Company PLC | NYSE | 17 Jul 2026 | 10.27 | 11.36 | 9.81 | 10.72 | 4.38% |